fda glp-1 compounding crackdown news october 2025 Despite crackdown, unapproved GLP-1s still threaten the industry FDA GLP-1 Compounding Crackdown |

#GLP1 #Noom #ObesityTreatment #DigitalHealth #WeightLoss #Semaglutide #HealthTech #CompoundedDrugs #PharmaInnovation #BehavioralHealth

This analysis in #JCOOP showed a nearly 30% drop in incidencefrom 2.3% to 1.6% and it has generated a lot of discussion

I'm spilling the tea on my hydration, portion control, and healthy snack tips

The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its other GLP-1 products.

The outcomes that matter, in other words

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease...